CB42332-21 - 0x00000000000063DF

Healthy Males & Females

Action

* Stipend may pay up to reflected amount.
Start Date: 
May 6, 2025 - 7:30am
End Date: 
June 3, 2025 - 1:00pm

Study Details

Study Number: CB42332
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat an inherited disorder that causes muscle and sensation loss called Charcot-Marie-Tooth disorder.
Route of Administration: Oral
Blood Draws: 47

Study Schedule

Schedule Type: Long Term
Study Length: 17 Night Stay, 1 Return & 1 Phone Call

Screening Dates:

Event Day Event Date
Tuesday 4/29/2025
Friday 5/2/2025
Monday 5/5/2025
Tuesday 5/6/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 4/29/2025
Friday 5/2/2025
Monday 5/5/2025
Tuesday 5/6/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 5/6/2025 7:30:00 AM Friday 5/23/2025 10:15:00 AM 1 Lincoln
Return Tuesday 5/27/2025 8:45:00 AM Tuesday 5/27/2025 10:15:00 AM 1 Lincoln
Phone participant Tuesday 6/3/2025 1:00:00 PM 1 Lincoln